MN HF2004

Authorizes incentives for drug manufacturers who import multimarket-approved (MMA) products that are at least 23 percent lower in cost than FDA-approved U.S.-manufactured equivalents.

Requires MMA products meeting the 23 percent cost threshold to be included on Minnesota's uniform preferred drug list and covered under medical assistance, MinnesotaCare, and state employee group insurance programs.

Health plan companies must provide coverage for qualifying MMA products without imposing any enrollee cost-sharing requirements if the U.S.-manufactured version is already covered.

Applies only to MMA products where manufacturers have obtained a new National Drug Code and imported the product in compliance with federal Food, Drug, and Cosmetic Act requirements and FDA importation guidance.

Incentives become effective only upon affirmative action by the legislature.